Changhao Zhang

Changhao Zhang

Auto-generated profile, based on publicly available information

Changhao Zhang

Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, College of Pharmacy, Yanbian University, Yanji 133002, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2015 in Natural Product Research
Verified
Journal Article
Closed access
MJMei Jin
Mei Jin
SDShengbao Diao
Shengbao Diao
CZChanghao Zhang
Changhao Zhang
SCShuo Cao
Shuo Cao
JSJinfeng Sun
Jinfeng Sun
GLGao Li
Gao Li
Two new diarylheptanoids, ( - )-threo-3',4″-epoxy-1-(4-hydroxyphenyl)-7-(3-methoxyphenyl)heptan-2,3-diol (1) and (1α,3β,5α,6α)-1,5-epoxy-3,6-dihydroxy-1,7-bis(3-methoxy-4-hydroxy-phenyl)-heptane (2), along with one known diarylheptanoid, rhoiptelol B (3), were isolated from the roots of Juglans mandshurica. The structures of compounds 1 and 2 were identified based on HR-ESI-MS, 1D and 2D NMR including (1)H-(1)H COSY, HMQC, HMBC and NOESY spectroscopic methods.

4 April 2014 in Natural Product Research
Verified
Journal Article
Closed access
DYDalei Yao
Dalei Yao
MJMei Jin
Mei Jin
CZChanghao Zhang
Changhao Zhang
JLJie Luo
Jie Luo
RLRen Li
Ren Li
GLGao Li
Gao Li
A new phenolic glycoside, 6-O-(4'-hydroxy-3',5'-dimethoxybenzoyl)-d-glucopyranose (4), and nine known compounds (1-3 and 5-10) were isolated from Juglans mandshurica Maxim. Compound structures were elucidated by NMR, HR-ESI-MS and acid hydrolysis. Compounds 5 and 6 are reported from this genus for the first time. Among compounds 1-10, only 1 exhibited cytotoxicity against MGC-803, A549, K562, JAR, HeLa, CaSKi and SiHa cell lines (IC50: 2.0, 5.3, 2.3, 6.9, 4.0, 6.6 and 2.7 μM, respectively).

18 January 2025 in Journal of Advanced Research
Verified
Journal Article
Open access
JZJing Zhang
Jing Zhang
LLLiang Luan
Liang Luan
YXYoudong Xu
Youdong Xu
SJShuyuan Jiang
Shuyuan Jiang
WZWenpeng Zhang
Wenpeng Zhang
QMQingbin Meng
Qingbin Meng
In recent years, cationic amphipathic antimicrobial peptides (AMPs) have shown great promise in combating antibiotic resistance on account of their distinctive membrane-disruptive mechanism. However, the clinical application of AMPs is restricted by their unsatisfactory stability and safety. Although attempts have been made to improve the stability and safety of AMPs, many of them are accompanied by a decline in their antimicrobial activity and bacterial selectivity. To develop AMPs with excellent and balanced antimicrobial activity, stability, and safety using a combination strategy. A series of sC184b-derived peptide analogues were designed by a combination strategy of subtly adjusting the charges, hydrophobic properties, and introducing specific unnatural amino acids in a well-balanced manner. The antimicrobial activity, cytotoxicity, hemolytic activity, stability, anti-biofilm activity, mechanism of action, synergistic effects, in vivo efficacy, and pharmacokinetics of the analogues were evaluated. Among these analogues, P-α-02-B stood out for its broad-spectrum and potent antimicrobial activity, anti-biofilm activity, desirable bacterial selectivity, high plasma stability, and synergistic effect with antibiotic levofloxacin. P-α-02-B exhibited strong membrane disturbance effect, which could be explained by its rigid α-helical structure revealed by molecular dynamics simulations. More importantly, P-α-02-B showed favorable therapeutic efficacy in vivo, whether used alone or in combination with levofloxacin. P-α-02-B is a promising antimicrobial agent for MDR bacterial infections, demonstrating the effectiveness of the combination strategy for AMP development.

4 February 2024 in Biochemical Systematics and Ecology
Verified
Journal Article
Closed access
PDPeng Du
Peng Du
NWNan Wu
Nan Wu
XYXiongjie Yin
Xiongjie Yin
CCChengyu Cui
Chengyu Cui
JJJunyi Jin
Junyi Jin
CZChanghao Zhang
Changhao Zhang

17 May 2022 in Nanotechnology
Verified
Journal Article
Closed access
XLXuexue Liu
Xuexue Liu
XZXiang Zhang
Xiang Zhang
JCJian Chen
Jian Chen
CZChanghao Zhang
Changhao Zhang
SFSongke Feng
Songke Feng
WZWeiguo Zhang
Weiguo Zhang
Dendritic fibrous nanosilica (DFNS) is a suitable nano-carrier for loading pesticides with radially oriented pores and a large surface area. The microemulsion method is standard method to prepare DFNS, and 1-pentanol is taken to replace cyclohexane as an oil solvent due to its high stability and nontoxic property. The results showed that the volume ratio of 1-pentanol (oil) to water (O/W) and the molar ratio of hexadecyltrimethylammonium bromide (CTAB) to tetraethylorthosilicate (TEOS) had effected on morphology and adsorption properties of DFNS in the water-CTAB-1-pentanol-ethanol-trimethylbenzene (TMB) microemulsion system. DFNS with bicontinuous concentric lamellar morphologies can be synthesized in this microemulsion at the meager O/W volume ratio (0.025–0.045). It features a tight mesoporous structure with a thin dendritic fibrous in 0.03 to 0.04 O/W volume ratio. The particle sizes, surface areas, and porosity of DFNS were positively correlated with the addition of the silica precursor TEOS. The size of DFNS increased from 123 to about 220 nm with the CTAB/TEOS molar ratio decreasing from 0.119 to 0.050. When the molar ratio of CTAB to TEOS = 0.119, DFNS has a smaller particle size (123 nm) with a larger surface area and abundant honeycomb mesopores; the low O/W volume ratio strategy provides theoretical support for the industrialization development of DFNS and nano-pesticides, which plays a profound role in promoting the sustainable development of pesticide reduction, efficiency and green agriculture.